Difficulty: Medium
Average Score: 86%
Practice
A 9-year-old nephrotic syndrome patient with a history of thromboembolism. All the following agents may minimize the risk of clots EXCEPT
Correct answer
D
Rationale
In pediatric genitourinary nursing interventions for a 9-year-old with nephrotic syndrome and a history of thromboembolism, understanding pharmacological interventions is crucial. In this scenario, the correct answer is D) clopidogrel.
Clopidogrel is an antiplatelet agent that helps to prevent blood clots by inhibiting platelet aggregation. This mechanism differs from the other options provided. Warfarin (A) is a common anticoagulant that works by inhibiting vitamin K-dependent clotting factors. Lovenox (B) is a low molecular weight heparin that also prevents clot formation. Low-dose aspirin (C) is an antiplatelet agent like clopidogrel but is not the best choice for a patient with a history of thromboembolism due to its potential to increase bleeding risk.
Educationally, understanding the mechanisms of action of various anticoagulants and antiplatelet agents is crucial for safe and effective pediatric patient care. It is essential to differentiate between these agents to provide individualized treatment plans based on the patient's condition, history, and risk factors. In this case, choosing clopidogrel over the other options helps minimize the risk of clots while considering the patient's specific needs and medical history.
Clopidogrel is an antiplatelet agent that helps to prevent blood clots by inhibiting platelet aggregation. This mechanism differs from the other options provided. Warfarin (A) is a common anticoagulant that works by inhibiting vitamin K-dependent clotting factors. Lovenox (B) is a low molecular weight heparin that also prevents clot formation. Low-dose aspirin (C) is an antiplatelet agent like clopidogrel but is not the best choice for a patient with a history of thromboembolism due to its potential to increase bleeding risk.
Educationally, understanding the mechanisms of action of various anticoagulants and antiplatelet agents is crucial for safe and effective pediatric patient care. It is essential to differentiate between these agents to provide individualized treatment plans based on the patient's condition, history, and risk factors. In this case, choosing clopidogrel over the other options helps minimize the risk of clots while considering the patient's specific needs and medical history.